1. Home
  2. FAMI vs PFSA Comparison

FAMI vs PFSA Comparison

Compare FAMI & PFSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Farmmi Inc.

FAMI

Farmmi Inc.

BUY

Current Price

$1.44

Market Cap

7.8M

ML Signal

BUY

PFSA

Profusa Inc.

N/A

Current Price

$0.11

Market Cap

8.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FAMI
PFSA
Founded
2015
2009
Country
China
United States
Employees
N/A
N/A
Industry
Packaged Foods
Medical/Dental Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.8M
8.9M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
FAMI
PFSA
Price
$1.44
$0.11
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
600.1K
60.0M
Earning Date
08-04-2025
02-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$43,831,754.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
122.22
52 Week Low
$1.11
$0.07
52 Week High
$3.64
$12.76

Technical Indicators

Market Signals
Indicator
FAMI
PFSA
Relative Strength Index (RSI) 55.87 N/A
Support Level $1.11 N/A
Resistance Level $1.43 N/A
Average True Range (ATR) 0.14 0.00
MACD 0.02 0.00
Stochastic Oscillator 79.09 0.00

Price Performance

Historical Comparison
FAMI
PFSA

About FAMI Farmmi Inc.

Farmmi Inc is an investment holding company. Through its subsidiaries, it acts as a supplier of agricultural products. It is an agricultural technology enterprise focused on its supply chain platform by promoting edible mushroom products and agriculture technology. Its product offerings include tapioca, corn, red dates, shiitake mushrooms, mu er fungus, other edible fungi, and other agricultural products. Geographically, the company's products are sold in China, Southeast Asia, Japan, North America, Europe, and the Middle East under the Forasen and Farmmi brands.

About PFSA Profusa Inc.

Profusa Inc is a clinical-stage digital health and medical technology company focused on developing biosensing solutions to improve health outcomes for patients with a variety of different diseases and conditions. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.

Share on Social Networks: